RT Journal Article
SR Electronic
T1 301 Preclinical development of AB-2100, a PSMA neovasculature-inducible CA9 CAR resistant to FASL and TGFb mediated suppression for the treatment of ccRCC
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A344
OP A344
DO 10.1136/jitc-2023-SITC2023.0301
VO 11
IS Suppl 1
A1 Scarfo, Irene
A1 Lim, Laura
A1 Dang, Kevin
A1 Chew, Marvin
A1 Sudhakah, Rakesh
A1 Nguyen, Michelle
A1 Mohanty, Suchismita
A1 Chen, Jeremy
A1 Gomez, Alma
A1 Attanasio, Nickolas
A1 Fearon, Amanda
A1 Chan, Ivan
A1 Sail, Vibhavari
A1 Gardner, Thomas J
A1 Millare, Beatriz
A1 Zhang, James
A1 Moskowitz, Darrian
A1 Thomas, Vince
A1 Zhou, Stanley
A1 Smith, Jenessa
A1 McDevitt, Jennifer
A1 Boroughs, Angela
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A344.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.